The future of cardiovascular regenerative medicine

Circulation

Volumn 133, Issue 25, 2016, Pages 2618-2625

  Lee, Richard T ^a,b   Walsh, Kenneth ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Harvard University   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

genetics; heart failure; pharmaceutical preparations

Indexed keywords

ACUTE HEART INFARCTION; ADULT STEM CELL; ARTICLE; CARDIAC MUSCLE CELL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR TISSUE; CELL DIFFERENTIATION; CELL THERAPY; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; CORONARY ARTERY THROMBOSIS; CYTOLOGY; DIABETES MELLITUS; EXOCRINE CELL; GENE TARGETING; GENETIC BACKGROUND; GENETIC RISK; GENOME ANALYSIS; HEART FAILURE; HEART FIBROBLAST; HEART TRANSPLANTATION; HEART VENTRICLE ARRHYTHMIA; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN EMBRYONIC STEM CELL; HUMAN GENETICS; HUMAN GENOME; INDUCED PLURIPOTENT STEM CELL; ISCHEMIC CARDIOMYOPATHY; LONG QT SYNDROME; MOUSE EMBRYONIC STEM CELL; MUSCLE REGENERATION; NANOTECHNOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR REPROGRAMMING; OBESITY; PANCREAS ISLET BETA CELL; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGENERATIVE MEDICINE; SKIN FIBROBLAST; STEM CELL SELF-RENEWAL; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; ADVERSE EFFECTS; ANIMAL; CARDIAC MUSCLE; CARDIOLOGY; CARDIOVASCULAR DISEASES; CONVALESCENCE; FORECASTING; GENE THERAPY; GENETICS; MASS COMMUNICATION; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATION; TISSUE ENGINEERING; TRENDS;

ANIMALS; CARDIOLOGY; CARDIOVASCULAR DISEASES; DIFFUSION OF INNOVATION; FORECASTING; GENETIC THERAPY; HUMANS; MYOCARDIUM; RECOVERY OF FUNCTION; REGENERATION; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

EID: 84975889708     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.115.019214     Document Type: Article

References (54)

1. Rink JC, Stem cell systems and regeneration in planaria. Dev Genes Evol 2013 223 67 84. doi: 10.1007/s00427-012-0426-4
2. Goss RJ, Principles of Regeneration 1969 New York, NY Academic Press
3. Behfar A, Crespo-Diaz R, Terzic A, Gersh BJ, Cell therapy for cardiac repair-lessons from clinical trials. Nat Rev Cardiol 2014 11 232 246. doi: 10.1038/nrcardio.2014.9
4. Rosen MR, Myerburg RJ, Francis DP, Cole GD, Marbán E, Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement. J Am Coll Cardiol 2014 64 922 937. doi: 10.1016/j.jacc.2014.06.1175
5. Telukuntla KS, Suncion VY, Schulman IH, Hare JM, The advancing field of cell-based therapy: insights and lessons from clinical trials. J Am Heart Assoc 2013 2 e000338. doi: 10.1161/JAHA.113.000338
6. Evans MJ, Kaufman MH, Establishment in culture of pluripotential cells from mouse embryos. Nature 1981 292 154 156
7. Martin GR, Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci U S A 1981 78 7634 7638
8. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM, Embryonic stem cell lines derived from human blastocysts. Science 1998 282 1145 1147
9. McCarthy M, US researchers push past stem-cell restrictions. States and private sources fund research denied federal support by Bush ban. Lancet 2004 363 868 869
10. He JQ, Ma Y, Lee Y, Thomson JA, Kamp TJ, Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res 2003 93 32 39. doi: 10.1161/01.RES.0000080317.92718.99
11. Murry CE, Keller G, Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 2008 132 661 680. doi: 10.1016/j.cell.2008.02.008
12. Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O'Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE, Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007 25 1015 1024. doi: 10.1038/nbt1327
13. Chong JJ, Yang X, Don CW, Minami E, Liu YW, Weyers JJ, Mahoney WM, Van Biber B, Cook SM, Palpant NJ, Gantz JA, Fugate JA, Muskheli V, Gough GM, Vogel KW, Astley CA, Hotchkiss CE, Baldessari A, Pabon L, Reinecke H, Gill EA, Nelson V, Kiem HP, Laflamme MA, Murry CE, Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 2014 510 273 277. doi: 10.1038/nature13233
14. Gerbin KA, Murry CE, The winding road to regenerating the human heart. Cardiovasc Pathol 2015 24 133 140. doi: 10.1016/j.carpath.2015.02.004
15. van Berlo JH, Molkentin JD, An emerging consensus on cardiac regeneration. Nat Med 2014 20 1386 1393. doi: 10.1038/nm.3764
16. Takahashi K, Yamanaka S, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006 126 663 676. doi: 10.1016/j.cell.2006.07.024
17. Gurdon JB, Elsdale TR, Fischberg M, Sexually mature individuals of Xenopus laevis from the transplantation of single somatic nuclei. Nature 1958 182 64 65
18. Braam SR, Passier R, Mummery CL, Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery. Trends Pharmacol Sci 2009 30 536 545. doi: 10.1016/j.tips.2009.07.001
19. Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ, Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009 104 e30 e41. doi: 10.1161/CIRCRESAHA.108.192237
20. Kamao H, Mandai M, Okamoto S, Sakai N, Suga A, Sugita S, Kiryu J, Takahashi M, Characterization of human induced pluripotent stem cell-derived retinal pigment epithelium cell sheets aiming for clinical application. Stem Cell Reports 2014 2 205 218. doi: 10.1016/j.stemcr.2013.12.007
21. Addis RC, Epstein JA, Induced regeneration-The progress and promise of direct reprogramming for heart repair. Nat Med 2013 19 829 836. doi: 10.1038/nm.3225
22. Zhou Q, Brown J, Kanarek A, Rajagopal J, Melton DA, In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 2008 455 627 632. doi: 10.1038/nature07314
23. Amamoto R, Arlotta P, Development-inspired reprogramming of the mammalian central nervous system. Science 2014 343 1239882. doi: 10.1126/science.1239882
24. Han JK, Chang SH, Cho HJ, Choi SB, Ahn HS, Lee J, Jeong H, Youn SW, Lee HJ, Kwon YW, Cho HJ, Oh BH, Oettgen P, Park YB, Kim HS, Direct conversion of adult skin fibroblasts to endothelial cells by defined factors. Circulation 2014 130 1168 1178. doi: 10.1161/CIRCULATIONAHA.113.007727
25. Qian L, Huang Y, Spencer CI, Foley A, Vedantham V, Liu L, Conway SJ, Fu JD, Srivastava D, In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes. Nature 2012 485 593 598. doi: 10.1038/nature11044
26. Song K, Nam YJ, Luo X, Qi X, Tan W, Huang GN, Acharya A, Smith CL, Tallquist MD, Neilson EG, Hill JA, Bassel-Duby R, Olson EN, Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 2012 485 599 604. doi: 10.1038/nature11139
27. Mandel Y, Weissman A, Schick R, Barad L, Novak A, Meiry G, Goldberg S, Lorber A, Rosen MR, Itskovitz-Eldor J, Binah O, Human embryonic and induced pluripotent stem cell-derived cardiomyocytes exhibit beat rate variability and power-law behavior. Circulation 2012 125 883 893. doi: 10.1161/CIRCULATIONAHA.111.045146
28. Nallamothu BK, Bates ER, Wang Y, Bradley EH, Krumholz HM, Driving times and distances to hospitals with percutaneous coronary intervention in the United States: implications for prehospital triage of patients with ST-elevation myocardial infarction. Circulation 2006 113 1189 1195. doi: 10.1161/CIRCULATIONAHA.105.596346
29. Desta L, Jernberg T, Löfman I, Hofman-Bang C, Hagerman I, Spaak J, Persson H, Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The SWEDEHEART Registry (Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies): a study of 199,851 patients admitted with index acute myocardial infarctions, 1996 to 2008. JACC Heart Fail 2015 3 234 242. doi: 10.1016/j.jchf.2014.10.007
30. Menasché P, Vanneaux V, Hagège A, Bel A, Cholley B, Cacciapuoti I, Parouchev A, Benhamouda N, Tachdjian G, Tosca L, Trouvin JH, Fabreguettes JR, Bellamy V, Guillemain R, Suberbielle Boissel C, Tartour E, Desnos M, Larghero J, Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Eur Heart J 2015 36 2011 2017. doi: 10.1093/eurheartj/ehv189
31. Braunwald E, The path to an angiotensin receptor antagonist-neprilysin inhibitor in the treatment of heart failure. J Am Coll Cardiol 2015 65 1029 1041. doi: 10.1016/j.jacc.2015.01.033
32. Itzhaki I, Maizels L, Huber I, Zwi-Dantsis L, Caspi O, Winterstern A, Feldman O, Gepstein A, Arbel G, Hammerman H, Boulos M, Gepstein L, Modelling the long QT syndrome with induced pluripotent stem cells. Nature 2011 471 225 229. doi: 10.1038/nature09747
33. Lander ES, Initial impact of the sequencing of the human genome. Nature 2011 470 187 197. doi: 10.1038/nature09792
34. Björkegren JL, Kovacic JC, Dudley JT, Schadt EE, Genome-wide significant loci: how important are they? Systems genetics to understand heritability of coronary artery disease and other common complex disorders. J Am Coll Cardiol 2015 65 830 845. doi: 10.1016/j.jacc.2014.12.033
35. Eschenhagen T, Mummery C, Knollmann BC, Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes. Cardiovasc Res 2015 105 424 438. doi: 10.1093/cvr/cvv017
36. Masumoto H, Ikuno T, Takeda M, Fukushima H, Marui A, Katayama S, Shimizu T, Ikeda T, Okano T, Sakata R, Yamashita JK, Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration. Sci Rep 2014 4 6716. doi: 10.1038/srep06716
37. Terrenoire C, Wang K, Tung KW, Chung WK, Pass RH, Lu JT, Jean JC, Omari A, Sampson KJ, Kotton DN, Keller G, Kass RS, Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics. J Gen Physiol 2013 141 61 72. doi: 10.1085/jgp.201210899
38. Hinson JT, Chopra A, Nafissi N, Polacheck WJ, Benson CC, Swist S, Gorham J, Yang L, Schafer S, Sheng CC, Haghighi A, Homsy J, Hubner N, Church G, Cook SA, Linke WA, Chen CS, Seidman JG, Seidman CE, HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy. Science 2015 349 982 986. doi: 10.1126/science.aaa5458
39. Doudna JA, Charpentier E, Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 2014 346 1258096. doi: 10.1126/science.1258096
40. Doudna JA, Genomic engineering and the future of medicine. JAMA 2015 313 791 792. doi: 10.1001/jama.2015.287
41. Ding Q, Strong A, Patel KM, Ng SL, Gosis BS, Regan SN, Cowan CA, Rader DJ, Musunuru K, Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing. Circ Res 2014 115 488 492. doi: 10.1161/CIRCRESAHA.115.304351
42. Tebas P, Stein D, Tang WW, Frank I, Wang SQ, Lee G, Spratt SK, Surosky RT, Giedlin MA, Nichol G, Holmes MC, Gregory PD, Ando DG, Kalos M, Collman RG, Binder-Scholl G, Plesa G, Hwang WT, Levine BL, June CH, Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. N Engl J Med 2014 370 901 910. doi: 10.1056/NEJMoa1300662
43. Baltimore D, Berg P, Botchan M, Carroll D, Charo RA, Church G, Corn JE, Daley GQ, Doudna JA, Fenner M, Greely HT, Jinek M, Martin GS, Penhoet E, Puck J, Sternberg SH, Weissman JS, Yamamoto KR, Biotechnology. A prudent path forward for genomic engineering and germline gene modification. Science 2015 348 36 38. doi: 10.1126/science.aab1028
44. Lanphier E, Urnov F, Haecker SE, Werner M, Smolenski J, Don't edit the human germ line. Nature 2015 519 410 411. doi: 10.1038/519410a
45. Long C, McAnally JR, Shelton JM, Mireault AA, Bassel-Duby R, Olson EN, Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA. Science 2014 345 1184 1188. doi: 10.1126/science.1254445
46. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisén J, Evidence for cardiomyocyte renewal in humans. Science 2009 324 98 102. doi: 10.1126/science.1164680
47. Lee J, Sayed N, Hunter A, Au KF, Wong WH, Mocarski ES, Pera RR, Yakubov E, Cooke JP, Activation of innate immunity is required for efficient nuclear reprogramming. Cell 2012 151 547 558. doi: 10.1016/j.cell.2012.09.034
48. Sayed N, Wong WT, Ospino F, Meng S, Lee J, Jha A, Dexheimer P, Aronow BJ, Cooke JP, Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity. Circulation 2015 131 300 309. doi: 10.1161/CIRCULATIONAHA.113.007394
49. Zakrzewski JL, van den Brink MR, Hubbell JA, Overcoming immunological barriers in regenerative medicine. Nat Biotechnol 2014 32 786 794. doi: 10.1038/nbt.2960
50. Zhao T, Zhang ZN, Rong Z, Xu Y, Immunogenicity of induced pluripotent stem cells. Nature 2011 474 212 215. doi: 10.1038/nature10135
51. Riolobos L, Hirata RK, Turtle CJ, Wang PR, Gornalusse GG, Zavajlevski M, Riddell SR, Russell DW, HLA engineering of human pluripotent stem cells. Mol Ther 2013 21 1232 1241. doi: 10.1038/mt.2013.59
52. Hsieh PC, Davis ME, Lisowski LK, Lee RT, Endothelial-cardiomyocyte interactions in cardiac development and repair. Annu Rev Physiol 2006 68 51 66. doi: 10.1146/annurev.physiol.68.040104.124629
53. Kakkar R, Lee RT, Intramyocardial fibroblast myocyte communication. Circ Res 2010 106 47 57. doi: 10.1161/CIRCRESAHA.109.207456
54. Walsh K, Shiojima I, Cardiac growth and angiogenesis coordinated by intertissue interactions. J Clin Invest 2007 117 3176 3179. doi: 10.1172/JCI34126